WESTMINSTER RADAR
Search
My MPs
Menu

Question follow-through · 97255

Drugs: USA

To ask the Secretary of State for Business and Trade, what the mitigations are under the US Most Favoured Nation drug pricing initiative as referred to in the UK-US Economic Prosperity Deal.

answeredDepartment for Business and Trade

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department for Business and Trade
Tabled
4 Dec 2025
Target answer date
9 Dec 2025
Answer
9 Dec 2025 · 5 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Economy and business

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 4 Dec 2025

    Question tabled

    To ask the Secretary of State for Business and Trade, what the mitigations are under the US Most Favoured Nation drug pricing initiative as referred to in the UK-US Economic Prosperity Deal.

  2. 9 Dec 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 9 Dec 2025

    Answer published

    The US has committed to ensuring that access to medicines and launches of new innovative medicines in the UK are not inadvertently impacted by the US’s ‘Most Favoured Nation’ policy, thereby reducing the risk to the UK where the NHS has managed to secure ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Strong linkSame MP, department and exact heading

Drugs: USA

5 Dec 2025 · To ask the Secretary of State for Business and Trade, what mechanisms within the UK-US Economic Prosperity Deal will ensure that pharmaceutical products launched in the UK with a lower price than in the US will not trigger Most Favoured Nation rebates.

Strong linkSame MP, department and exact heading

Drugs: USA

5 Dec 2025 · To ask the Secretary of State for Business and Trade, with reference to the US Trade Representative's press release entitled U.S. Government Announces Agreement in Principle with the United Kingdom on Pharmaceutical Pricing, published on 1 December 2025,

Strong linkSame MP, department and exact heading

Drugs: USA

12 Dec 2025 · To ask the Secretary of State for Business and Trade, pursuant to the answer of 9 December 2025 to Question 97256, what his planned timeframe is for the further work to finalise underpinning details to be completed.

Strong linkSame MP, department and exact heading

Drugs: USA

12 Dec 2025 · To ask the Secretary of State for Business and Trade, pursuant to the answer of 10 December 2025 to Question 97685, whether any additional commitments have been made by the UK in relation to UK-US agreement on pharmaceutical in addition to the increased s

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Trade Agreements: USA

12 Dec 2025 · To ask the Secretary of State for Business and Trade, if he will publish the full legal texts establishing the MFN mitigations with the US.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Artificial Intelligence and Automation: Employment

21 May 2026 · To ask the Secretary of State for Business and Trade, what assessment he has made of the impact of increases in employment costs on businesses’ decisions on whether to substitute labour with (a) automation and (b) AI.